000			02123 a2200553 4500
005			20250513194636.0
264		0	_c20000118
008			200001s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1999.17.11.3412 _2doi
040			_aNLM _beng _cNLM
100	1		_aBuzdar, A U
245	0	0	_aProspective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 1999
300			_a3412-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Phytogenic _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aProspective Studies
700	1		_aSingletary, S E
700	1		_aTheriault, R L
700	1		_aBooser, D J
700	1		_aValero, V
700	1		_aIbrahim, N
700	1		_aSmith, T L
700	1		_aAsmar, L
700	1		_aFrye, D
700	1		_aManuel, N
700	1		_aKau, S W
700	1		_aMcNeese, M
700	1		_aStrom, E
700	1		_aHunt, K
700	1		_aAmes, F
700	1		_aHortobagyi, G N
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 17 _gno. 11 _gp. 3412-7
856	4	0	_uhttps://doi.org/10.1200/JCO.1999.17.11.3412 _zAvailable from publisher's website
999			_c10506783 _d10506783